|
|
|
|
|
Single-Use Applications for Biopharmaceutical Manufacturing
2011年6月6-8日 、 Sheraton Boston Hotel 、 Boston, MA
單次使用技術在生物醫藥品製造領域迅速一般化。該技術造成減少成本的效果及具備相當出色的柔軟性、以及轉換方向快速,已經不容置疑。然隨著製藥業界單次使用技術的普及,亦浮現許多疑點。
以高水準重點會議及有出色的科學諮詢委員會而廣為人所知的此學會,每次都提出刺激的問題及獨創性的解決方法,撥動參加者對知識的好奇心,此次會議亦深受矚目。
FDA's Perspectives and Guidance on Single-Use
Anastasia G. Lolas, M.S.
Microbiologist, Biotech Manufacturing Team/MAPCB/DMPQ, Office of Compliance
CDER, FDA (invited)
Bravely Deploying Single-Use Technologies at Commercial Scale: How Project Atlas Leveraged Single-Use Technology to Achieve Lower Cost, More Flexible Manufacturing
William (Bill) Ciambrone
Senior Vice President Technical Operations
Shire Human Genetic Therapies
Multi-Purpose Facility Use, Multi-Product Facility Manufacturing, Vaccines and Biotherapeutics
Kent Murphy, Ph.D.
Senior Director, Operations Management
Pfizer, Inc.
Copyright IBC Life Sciences, a part of Informa Life Sciences Group 中文官方網站營運 : IBC Life Sciences 代理商 日商環球訊息有限公司
Powered by Interactive Agency Janmedia Interactive, Inc.